Latest News

Moderna Will Have to Wait for FDA Approval of Investigational RSV Vaccine
Moderna Will Have to Wait for FDA Approval of Investigational RSV Vaccine

May 10th 2024

While Moderna expects mRNA-1345 to be approved later this month, the company cites FDA administrative constraints as reason for delay.

FDA Approves New Antibiotic for Uncomplicated UTI: Daily Dose / image credit: ©New Africa/AdobeStock
FDA Approves New Antibiotic for Uncomplicated UTI: Daily Dose

May 3rd 2024

COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone: Daily Dose / image credit: ©New Africa/AdobeStock
COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone: Daily Dose

April 30th 2024

©yankovych/stock.adobe.com
Merck's 21-Valent Pneumococcal Vaccine Delivers More Positive Phase 3 Data in Advance of 6-17-2024 PDUFA Date

April 29th 2024

Shingrix Effective Against Shingles for up to 11 Years Post-Vaccination: Daily Dose / image credit: ©New Africa/AdobeStock
Shingrix Effective Against Shingles for up to 11 Years Post-Vaccination: Daily Dose

April 25th 2024

© 2024 MJH Life Sciences

All rights reserved.